Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21837752 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Multiple Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Genotype 1 Infected Subjects
Condition: Chronic Hepatitis C
Interventions: Drug: Daclatasvir;   Drug: Placebo

Indicates status has not been verified in more than two years